Loading...
Options B.R.O.
Example search prompt
Example search prompt
Example search prompt
Example search prompt
The earnings season is picking up pace—and Q3 results 2026 are firmly back in focus today.January 23, 2026, is shaping up to be one of the busiest days of this quarter’s results calendar. As per exchange schedules from NSE and BSE, 54 listed companies are set to announce their Q3 results 2026, gi...
The Indian stock market witnessed its third consecutive day of losses on Wednesday, January 21, though the declines were moderate, thanks to a sharp recovery in the latter half of the session. Investors appeared cautious amid global uncertainties and mixed domestic signals.Market Performance: Nif...
India’s Contract Development and Manufacturing Organisation (CDMO) sector is once again gaining strong investor attention, supported by global supply-chain diversification, competitive cost structures, and favourable policy momentum. As the US moves ahead with the Biosecure Act, companies with hi...
The shares of Laurus Labs witnessed a sharp movement on October 24, reflecting investor caution despite impressive quarterly results. After touching a near all-time high in early trade, the stock experienced a notable decline as profit booking entered the market.Market PerformanceLaurus Labs open...
The earnings season continues post-Diwali 2025, with several marquee names set to announce their Q2 results. Investors are closely watching Hindustan Unilever Ltd (HUL), Colgate Palmolive (India) Ltd, and PTC India Financial Services Ltd, as their Q2 results are expected to offer key insights int...
Indian pharmaceutical shares saw notable gains today as the US Senate passed the Biosecure Act, a development expected to reshape biotech sourcing and supply chains.Market PerformanceNifty Pharma climbed 1.56% by midday.Leading gainers included Divi's Labs (+5%), Piramal Pharma (+4.36%), and Wock...
Market PerformanceThe Nifty Pharma Index rose 1.9% during intraday trades on Wednesday, marking a strong relief rally in the Indian stock market.Opening level: 21,803.45Previous close: 21,753.50Intraday high: 22,171.05Leading the gains were Alkem Laboratories, Zydus Lifesciences, Laurus Labs, and...
Market PerformanceAfter four consecutive sessions of declines, Indian equity markets experienced a strong rebound on Tuesday, July 15, with both benchmark indices closing in the green.Sensex closed at 82,570.91, up by 317 points or 0.39%Nifty 50 settled at 25,195.80, gaining 114 points or 0.45%Th...
Market PerformanceThe Indian stock market remained on a declining path for the fourth consecutive day on Monday, July 14.Sensex closed at 82,253.46, down by 247 points or 0.30%Nifty 50 ended at 25,082.30, falling 68 points or 0.27%4-Day Slide Summary:Sensex lost 1,459 points (down 1.74%)Nifty 50 ...
Market Performance: Sensex and Nifty Extend LossesThe Indian stock market witnessed another day in the red as benchmark indices fell for the second consecutive session on Thursday, July 10.Sensex closed at 83,190.28, down 345.80 points or 0.41%Nifty 50 settled at 25,355.25, losing 120.85 points o...
The Indian stock market experienced a cautious trading session on Wednesday, July 9, as major indices closed in the red. Rising concerns around US tariffs and anticipation ahead of corporate earnings kept investor sentiment subdued.In this detailed update, we break down the key market highlights,...
Market PerformanceIndian pharmaceutical stocks traded with mild gains on July 9 despite unsettling geopolitical developments. The Nifty Pharma Index was trading at 22,252.50, up 0.4% as of 9:25 a.m.Month-to-date performance: The Nifty Pharma index gained 0.6% so far in July.Year-to-date movement:...
Market PerformanceOn July 8, Indian pharmaceutical stocks experienced a notable dip in early trade as global trade tensions escalated. The Nifty Pharma index slipped nearly 1%, hovering around 22,159 during morning hours.This marked the second straight day of losses for the index, after an extend...
Market Performance OverviewIndian benchmark indices closed on a muted note on Monday, with both the Sensex and the Nifty showing limited movement amid cautious investor sentiment.Sensex ended up 193.42 points or 0.23% at 83,432.89Nifty 50 closed up 55.7 points or 0.22% at 25,461Nifty Midcap Index...
Market OverviewOn April 11, 2025, pharmaceutical shares witnessed a notable upswing following the temporary suspension of reciprocal tariffs by the United States. This development helped reduce recession-related concerns and contributed to optimism in the pharma sector. The Nifty Pharma index rec...
Open Free Trading & Demat Account
Trusted by 5.5 Lakh+ Investors
By proceeding, you agree to our Privacy Policy and Terms and Conditions.
Easy & quick
1. Register on SCORES portal
2. Mandatory details for filling complaints on SCORES
Name | PAN | Address | Mobile | Number | E-mail ID
3. Benefits
Effective Communication
Speedy redressal of the grievances
